BIA submission to the HMT consultation on a single RD tax relief scheme .pdf

BIA webinar recording: The Spring Budget: what does it mean for life sciences?

National Biotechnology and Biomanufacturing Initiative briefing

Guide to the Government for BIA members (February 2023)

BIA submission to Spring Budget 2023

BIA has submitted its representation to HM Treasury for the Spring Budget 2023. 

Ready, Set, Patent? How to get ready for the Unitary Patent and the Unified Patent Court in 2023

UK biotech financing in 2022

The UK’s innovative life sciences and biotech sector secured its fifth best fundraising year ever in 2022, with £1,785 million raised by UK-headquartered public and private companies across the year. While positive, this overall figure masks a mixed picture for the sector.

MMIP Delivering the UK’s Life Sciences Manufacturing Strategy

Influencing and shaping our sector | BIA update: October 2022 - January 2023

BIA response to AMR national action plan call for evidence

The BIA has responded to the Department for Health and Social Care (DHSC)’s call for evidence on the next antimicrobial resistance (AMR) national action plan. Our response was developed with input from a range of BIA members working in the AMR space.